Incorporating wound healing strategies to improve palliation (symptom management) in patients with chronic wounds

Journal of Palliative Medicine

Volumn 10, Issue 5, 2007, Pages 1161-1189

  Alvarez, Oscar M ^a   Kalinski, Cathy ^a   Nusbaum, Jeanne ^a   Hernandez, Luz ^a   Pappous, Emanuel ^a   Kyriannis, Charles ^a   Parker, Rachelle ^a   Chrzanowski, Gail ^a   Comfort, Christopher P ^a  

^a Calvary Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; CODEINE; DESIPRAMINE; EMLA; FENTANYL; HYDROMORPHONE; IBUPROFEN; IMIPRAMINE; LIDOCAINE; METHADONE; METRONIDAZOLE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; OXYCODONE; SHORT ACTING DRUG; TETRACAINE; TRICYCLIC ANTIDEPRESSANT AGENT; ZINC OXIDE;

ATHERECTOMY; CHRONIC WOUND; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEBRIDEMENT; DECUBITUS; DIAPER DERMATITIS; DIET THERAPY; DRUG INHIBITION; DRUG LABELING; EXTERNAL BEAM RADIOTHERAPY; HEMOSIDEROSIS; HUMAN; ISCHEMIA; LEG ULCER; MEDICAL INSTRUMENTATION; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PALLIATIVE THERAPY; PREVALENCE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN CANCER; SKIN INJURY; URINE INCONTINENCE; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

ARTERIES; CHRONIC DISEASE; HUMANS; INCIDENCE; PAIN; PALLIATIVE CARE; PRESSURE ULCER; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; VARICOSE ULCER; WOUND HEALING;

EID: 35948988855     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2007.9909     Document Type: Review

References (187)

1. Lazarus, GS, Cooper DM, Knighton, DR, Percoraro RE, Rodeheaver G, Robson MC: Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994;130:489-493.
2. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA: The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Repair Regen 2004;12:163-168.
3. Phillips TJ, Machado F, Trout R, Porter J, Olin J, Falanga V: Prognostic indicators in venous ulcers. J Am Acad Dermatol 2000;43:627-630
4. Stadelman, W K, Diiggenis J: Impediment to wound healing. Am J Surg 1998;76:395-475.
5. Cuddigan J, Berlowitz DR, Ayello EA: pressure ulcers in america: prevalence, incidence and implications for the future: An Executive Summary of the National Pressure Ulcer Advisory Panel Monograph. Adv Skin Wound Care 2001;14:208-215.
6. Reifsnyder J, Magee, H: Development of pressure ulcers in patients receiving home hospice care. Wounds 2005;17:74-79.
7. Reifsnyder J, Hoplamazian LM, Maxwell TL: Preventing and treating pressure ulcers in hospice patients. Caring 2004;423:30-37.
8. Cuddigan J, Ayello EA, Sussman C, Baranoski S (eds): National Pressure Ulcer Advisory Panel Monograph, 2001, p. 153.
9. Tippett AW: Wounds at the end of life. Wounds 2005;17:91-98.
10. Alvarez OM, Kalinski C, Hernandez L, Comfort CP: Prevalence of fungating tumors and malignant skin wounds in hospitalized patients receiving palliative care: A retrospective review. (in preparation).
11. Clinical practice guidelines number 3: Pressure ulcers in adults. Prediction and prevention. Panel for the Prediction and Prevention of Pressure Ulcers in Adults. Rockville, MD: US Department of Health and Human Services. Agency for Health Care Policy and Research. 1992, AHCPR Publication 92-0047.
12. Alvarez OM: Pressure ulcers: Critical considerations in prevention and management. Clin Mater 1991;8:209-222.
13. Alvarez OM, Childs EJ: Pressure ulcers: Physical, supportive, and local aspects of management. Clin Podiatr Med Surg 1991;8:869-889.
14. Alvarez OM, Meehan M, Ennis W, Thomas DR, Ferris FD, Kennedy KL, Rogers R, Bradley M, Baker JJ, Fernandez Obregon A, Rodeheaver G: Chronic Wounds: Palliative management for the frail population. Wounds 2002;14(8 Suppl):5s-27s.
15. Norton D, McLaren R, Exton-Smith AN: An Investigation of Geriatric Nursing Problems in Hospitals. London: National Corporation for the Care of Old People, 1962.
16. Bergstrom N, Braden BJ, Laguzza A, Holman V: The Braden Scale for predicting pressure sore risk. Nurs Res 1987;36:205-210.
17. Lyder C, Yu C, Emerling J, Empleo-Frazier O, Mangat R, Stevenson D, Empleo-Frazier O, McKay J: Evaluating the predictive validity of the Braden Scale for pressure ulcer risk in blacks latino/Hispanic elders. Appl Nursing Res 1999;12:60-68.
18. Moody BL, Fanale JE, Thompson N, Villancourt D, Symonds G, Bonasoro C: Impact of staff education of pressure ulcer development in elderly hospitalized patients. Arch Intern Med 1988;148:2241-2243.
19. Hanson D, Langemo DK, Olson B, Hunter S, Sauvage TR, Burd C, Cathcart-Silberberg T: The prevalence and incidence of pressure ulcers in the hospice setting: Analysis of 2 methodologies. Am J Hos Palliat Care 1991;8:18-22.
20. Kosiak M: Etiology and pathology of ischemic ulcers. Arch Phys Med Rehab 1959;40:62-69.
21. Seiler WO, Stahelin HB: Decubitus ulcers: Treatment through 5 therapeutic principles. Geriatrics 1985;40:30-44.
22. Hignett S: Systematic review of patient handling activities starting in lying, sitting and standing positions. J Advanced Nurs 2003;41:545-552.
23. Goode PS, Allman, RM: The prevention and management of pressure ulcers. Med Clin North Am 1989;73:1511-1524.
24. Reed JW: Pressure ulcers in the elderly: Prevention and treatment utilizing the team approach. Md State Med J 1981;30:45.
25. Allman RM, Laprade CA, Noel LB: Pressure sores among hospitalized patients. Ann Intern Med 1986;105:337-342.
26. Horn SD, Bender SA, Ferguson ML, Smout RJ, et al: The national pressure ulcer long term care study: Pressure ulcer development in long term residents. J Am Geriatr Soc 2004;52:359-367.
27. Reuler JB, Cooney TG: The pressure sore: Pathophysiology and principles of management. Ann Intern Med 1981;94:661-667.
28. Witkowski JA, Parish LC: Histopathology of ischemic ulcers. Arch Phys Med Rehab 1959;40:61-66.
29. Wheatley DC, Daniel RK, Priest DL: Etiologic factors in pressure sores: An experimental model. Arch Phys Med Rehab 1981;62:492-499.
30. Bennett L, Kavner D, Lee BY: Shear vs. pressure as causative factors in skin blood flow occlusion. Arch Phys Med Rehab 1969;60:309-314.
31. van Rijswijk L, Polansky M: Predictors of time to healing deep pressure ulcers. Wounds 1994;6:159-165.
32. Thomas DR: Pressure ulcers In: Cassell CK, Cohen HJ, Lanson EB, Meier DE, (eds): Geriatric Medicine, 3rd ed. New York, NY: Springer, 1997, pp. 767-785.
33. Clinical Practice Guidelines Number 15. Treatment of Pressure Ulcers, Agency for Health Care Policy and Research. AHCPR Publication No. 95-0652. Rockville, MD: US Department of Health and Human Services, 1994, p. 12.
34. Ebright JR: Microbiology of chronic leg and pressure ulcers: Clinical significance and implications for treatment. Nurs Clin North Am 2005;40:207-216.
35. Alvarez OM, Massac E, Brown B: Management issues in the critical care of pressure ulcers. Fam Pract Recert 1990;12:78-104.
36. Lewis VL, Bailey MH, Pauloski G, Kind G, Bashioum RW, Hendrix RW: The diagnosis of osteomyelitis in patients with pressure sores. Plast Reconstr Surg 1988;81:229-232.
37. Livesley NJ, Chow AW: Infected pressure ulcers in elderly individuals. Clin Infect Dis 2002;35:1390-1396.
38. Enderle MD, Coerper S, Schweizer HP, Kopp AF, Thelen MH, Meisner C, Pressler H, Becker HD, Claussen C, Häring HU, Luft D: Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. Diabetes Care 1999;22:294-299.
39. Wendelken M, Markowitz L, Patel M, Alvarez OM: Objective, noninvasive wound assessment using B-mode ultrasonography. Wounds 2003;15:1-9.
40. Patel GK, Llewellyn M, Harding GK: Wound-related osteomyelitis: A case of containment not cure. Br Community Nurs 2004;9:S6-13.
41. rd: Chronic osteomyelitis: Results of treatment. Instr Course Lect 1990;39:495-508.
42. Ciampollini J, Harding KG: Pathophysiology of chronic bacterialosteomyelitis. Why do antibiotics fail so often? Postgrad Med J 2000;76:479-483.
43. Cunha BA: Osteomyelitis in elderly patients. Clin Infect Dis 2002;35:287-293.
44. Klein L, Gilroy K: Evaluating mattress overlays, and pressure relieving systems: A question of perception or reality? J Enterostomal Therapy 1989;16:58-62.
45. Judson R: Pressure sores. Med J 1983;1:553-555.
46. Jolley DJ, Wright R, McGowan S, Campbell DA, Sinclair RD, Montgomery KC: Preventing pressure ulcers with Australian medical sheepskin: An open-label, randomized, controlled trial. Med J Aust 2004;180:324-327.
47. Cullum N, McInnes E, Bell-Syer SE, Legwood R: Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev 2004;(3):CD001735.
48. National Pressure Ulcer Advisory Panel (NPUAP): 〈www.npuap.org〉 1989-2005. (Last accessed September 2006).
49. Medical Coverage Policy-Decisions: Pressure reducing therapy (#CAG-00017N) (Support Surfaces). 〈www.cms.hhs.gov/coverage/download/id4. pdf〉 (Last accessed September 2006).
50. Allman RM, Walker JM, Hart MK, Laprade CA, Noel LB, Smith CR: Air fluidized beds or conventional therapy for pressure sores: A randomized trial. Ann Intern Med 1987;107:641-648.
51. Vanderwee K, Grypdonck MK, Defloor T: Effectiveness of an alternating pressure air mattress for the prevention of pressure ulcers. Age Ageing 2005;34:261-267.
52. McKenney L: Provision of alternating air pressure mattresses in the community. Nurs Times 2004;100:54-56.
53. Mayrovitz HM, Sims N: Effects of support surface relief pressures on heel skin blood flow in persons with and without diabetes mellitus. Adv Skin Wound Care 2004;17(4 Pt 1):197-201.
54. Langer G, Schloemer G, Knerr A, Kuss O, Behrens J: Nutritional interventions for preventing and treating pressure ulcers. Cochrane Database Sys Rev 2004;3:1-25.
55. Finucaine TE, Christmas C, Travis K: Tube feeding in patients with advanced dementia: A review of the evidence. JAMA 1999;282:1365-1370.
56. Chernoff R: Tube feeding patients with dementia. Nutr Clin Pract 2006;21:142-146.
57. Jaul E, Singer P, Calderon-Margolet R: Tube feeding in the demented elderly with severe disabilities. Isr Med Assoc J 2006;8:870-874.
58. Taylor TV, Rimmer S, Day B, Butcher J, Dymock IW: Ascorbic acid supplementation in the treatment of pressure sores. Lancet 1974;ii:544-546.
59. Fria Soriano L, Vazquez MA, Maristany CP, Xandri Graupera JM, Wouters-Wesseling W, Wagenaar L: The effectiveness of oral nutritional supplementation in the healing of pressure ulcers. J Wound Care 2004;13:319-322.
60. Desneves KJ, Todorovic BE, Cassar A, Crowe TC: Treatment with supplementary argentine, vitamin C and zinc in patients with pressure ulcers: A randomized controlled trial. Clin Nutr 2005;24:979-987.
61. Cordeiro MB, Antonelli EJ, da Cunha DF, Junior AA, Junior VR, Vannucchi H: Oxidative stress and acute phase response in patients with pressure sores. Nutrition 2005;21:901-907.
62. Peterkofsky B: Ascorbate requirement for hydroxylation and secretion of procollagen: Relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr 1991;54(6 Suppl):1135S-1140S.
63. Landsdown AB, Mirastschijski U, Stubbs N, Scanlon E, Agren MS: Zinc in wound healing: Theoretical, experimental, and clinical aspects. Wound Repair Regen 2007;15:2-16.
64. Langemo D, Anderson J, Hanson D, Hunter S, Thompson P, Posthauer ME: Nutritional considerations in wound care. Adv Skin Wound Care 2006;19:297-298, 300, 303.
65. Agren MS, Ostenfeld U, Kellahave F, Gong Y, Raffin K, Crawford ME, Kiss K, Friis-Moller A, Gluud C, Jorgensen LN: A randomized, double-blind, placebo-controlled multicenter trial evaluation of topical zinc oxide for acute open wounds following pilonidal disease excision. Wound Repair Regen 2006;14:526-535.
66. Hutois CHR: How I explore diaper dermatitis. Rev Med Liege 2004;59:106-109.
67. Kalinski C, Nusbaum J, Laboy D, Hernandez L, Comfort CP, Alvarez, OM: Effect of a topical formulation containing lidocaine and zinc oxide on painfull skin wounds. Abstract presented at Symposiums for Advanced Wound Care and Wound Healing Society. Tampa, FL: April 27-May 2, 2007.
68. Alvarez OM, Markowitz L, Wendelken M, Parker R: Experience with pallaitve wound care in the outpatient setting: Prevalence of chronic wound types. (in preparation).
69. Abbade LP, Lastoria S: Venous ulcer: Epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol 2005;44:449-456.
70. Trent JT, Fallabella A, Eaglstein WH, Kirsner R: Venous ulcers: Pathophysiology and treatment options. Ostomy Wound Manage 2005;51:38-54.
71. Lorrimer KR, Harrison MB, Graham ID, Freidberg E, Davies B: Assessing venous ulcer population characteristics and practices in a home care community. Ostomy Wound Manage 2003;49:32-34, 38-40, 42-43.
72. Burton CS: Management of chronic and problem lower extremity wounds. Dermatol Clin 1993;11:767-773.
73. Patton D: Thrombophilia: New ideas about old problems. South Med J 1997;81:1277-1281.
74. Browse NL, Burnand KG: The cause of venous ulceration. Lancet 1982;320:243-245.
75. Coleridge-Smith, PD, Thomas P, Scurr JH, Dormandy JA: Causes of venous ulceration: A new hypothesis. Br Med J 1988;296:1726-1727.
76. Falanga V, Eaglstein WH: The "trap" hypothesis of venous ulceration. Lancet 1993;341:1006-1008.
77. Alinovi A, Bassissi P, Pini M: Systemic administration of antibiotics in the management of venous ulcers. A randomized clinical trial. J Am Acad Dermatol 1986;15(2 Pt 1):186-191.
78. Vignes S, Dupuy A: Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: A retrospective cohort study. J Eur Acad Dermatol Venereol 2006;20:818-822.
79. Burton CS: Venous ulcers. Am J Surg 1994;167:37s-41s.
80. Falanga V: Venous ulceration. Wounds 1996;8:102-108.
81. Phillips TJ, Dover JS: Continuing medical education: Leg ulcers. J Am Acad Dermatol 1991;25:965-987.
82. Moffatt CJ, McCullagh L, O'Connor T, Doherty DC, Hourican C, Stevens J, Mole T, Franks PJ: Randomized trial of four-layer and two-layer bandage systems in the management of chronic venous ulceration. Wound Repair Regen 2003;11:166-171.
83. Blair SD, Wright DDI, Backhouse CM, Riddle E, McCollum CN: Sustained compression and healing of chronic venous ulcers. BMJ 1988;297:1159-1161
84. Burnand KG, Layer GT: Graduated elastic stockings. Br Med J 1986;293:224-225.
85. Alvarez OM, Rogers RS, Booker J, Patel M: Treatment of painful skin ulcers with a biocellulose dressing containing lidocaine [abstract]. Wounds 2006;18:A36.
86. Alvarez OM, Waltrous L, Markowitz L, Wendelken M, Comfort, CP: Leg ulcer healing in patients receiving curative or palliative wound care: A 2-year experience in an outpatient setting. Wounds (abstract submitted).
87. Hackman DG: Medical management of peripheral arterial disease. JAMA. 2006;296:41-42.
88. Hankey GJ, Norman PE, Eikelboom JW: Medical treatment of peripheral arterial disease. JAMA 2006;295:547-553.
89. Sontheimer DL: Peripheral vascular disease: Diagnosis and treatment. Am Fam Physician 2006;73:1971-1976.
90. Niazi K, Kahn TH, Easley KA: Diagnostic utility of the two methods of ankle brachial index in the detection of peripheral arterial disease of lower extremities. Catheter Cardiovasc Interv 2006;68:788-792.
91. Wild SH, Byrne CD, Smith FB, Lee AJ, Fowkes FG: Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabetes Care 2006;29:637-642.
92. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American Association for Vascular Surgery/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines.: ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) - Summary of recommendations. J Vasc Interv Radiol 2006;17:1383-1397.
93. Rubin BJ: Plaque excision in the treatment of peripheral arterial disease. Perspect Vasc Surg Endovasc Ther 2006;18:47-53.
94. Amato B, Iuliano GP, Markabauoi AK, Piscitelli V, Masone S, Compagna R, Esposito G, Piscione F.et al: Endovascular procedures in critical leg ischemia of elderly patients. Acta Biomed 2005;76(Suppl 1):11-15.
95. Comfort CP, Alvarez OM: Significant ischemic pain relief following baloon angiography in 3 subjects with critical limb ischemia. Abstract presented at Symposium for Advanced Wound Care and Wound Healing Society. Tampa, FL: May 27-May 2, 2007.
96. White RJ, Cutting K, Kingsley A: Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manage 2006;52:26-58.
97. Davis SC, Cazzaniga AL, Eaglstein WH, Mertz PM: Over the counter topical antimicrobials: Effective treatments? Arch Dermatol Res 2005;297:190-195.
98. Silver S, Fung LE, Silver G: Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. J Ind Microbiol Biotechnol 2006;33:627-634.
99. Montori VM, Kavros SJ, Walsh EE, Rooke TW: Intermittent compression for non healing wounds in patients with limb ischemia. The Mayo Clinic Experience (1998-2000). Int Angiol 2002;21:360-366.
100. Konstantinos D, Nicolaides AN: Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality od life in patients with arterial claudication. Ann Surg 2005;241:39.
101. Grocott P: The palliative management of fungating malignant wounds. J Wound Care 2000;9:4-9.
102. Collier M: The assessment of patients with malignant fungating wounds: Hollistic approach Part 1. Nurs Times 1997;93(Suppl 44):1-4.
103. Naylor W: Using a new foam dressing in the care of fungating wounds. Br J Nurs 2001;10(Suppl 6):S24-S30.
104. Clarke L: Caring for fungating tumors. J Wound Care 1992;88:66-70.
105. Clark J: Metronidazole gel in managing malodorous fungating wounds. Br J Nurs 2002;11(Suppl 6):S54-S60.
106. McDonald A, Lesage P: Palliative management of pressure ulcers and malignant wounds in patients with advanced illness. J Palliat Med 2006;9:285-295.
107. Haisfield-Wolfe ME, Rund C: Malignant cutaneous wounds: A management protocol. Ostomy Wound Manage 1997;43:56-66.
108. Rosen T: Cutaneous metastasis. Med Clin North Am 1980;64:885-900.
109. Ivetic O, Lynne PA, Fungating and ulcerating malignant lesions: A review of the literature. J Adv Nurs 1990;15:83-88.
110. van Leeuwen BL, Houwerzijl M, Hoekstra HJ: Educational tips in the treatment of malignant ulcerating tumors of the skin. Eur J Surg Oncol 2000;26:506-508.
111. Seaman S: Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs 2006;22:185-193.
112. Naylor W: Malignant wounds: Aetiology and principles of management. Nurs Stand 2002;16:45-56.
113. Seegensschmeidt MH, Keiholz L, Altendorf-Hofman A, Urban A, Schell H, Hohenberger W, Sauer R: Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long term outcome: A 20 year experience. Int J Radiat Oncol Biol Phys 1999;4:607-118.
114. Fritz P, Hensley FW, Berns C, Harms W, Wannenmacher M: Long-term results of pulsed irradiation of skin metastasis from breast cancer. Effectiveness and sequalae. Strahlenther Onkol 2000;176:368-376.
115. Suit H, Spiro IJ: Soft tissue sarcomas: Radiation as a therapeutic option. Ann Acad Med Singapore 1996;25:855-861.
116. Kalinski C, Schnepf, M, Laboy, D, Hernandez L, Nusbaum J, McGrinder B, Comfort C, Alvarez OM: Effectiveness of a topical formulation containing metronidazole for wound odor and exudates control. Wounds 2005;17:84-90.
117. Naylor W: Symptom control in the management of fungating wounds. Worldwide Wounds. 2002. 〈www.worldwidewounds.com〉 (Last accessed September 2006).
118. Steed DL: Debridement. Am J Surg 2004;187:71s-74s.
119. Whitney J, Phillips L, Aslam R, Barbul A, Gottrup F, Gould L, Robson MC, Rodeheaver G, Thomas D, Stotts N: Guidelines for the treatment of pressure ulcers. Wound Repair Regen 2006;14:663-679.
120. Williams D, Enoch S, Miller D, Harris K, Price P, Harding KG: Effect of sharp debridement using curette on recalcitrant nonhealing venous ulcers: A concurrently controlled, prospective cohort study. Wound Repair Regen 2005;13:131-137.
121. Wiseman DM, Rovee DT, Alvarez OM: Wound Dressings: design and use. In: Cohen K, Diegelmann R, Linbladt WJ (eds): Biochemical and Clinical Aspects of Wound Healing. Philadelphi, PA: WB Saunders, 1999, pp. 562-580.
122. Westerhoff W: Future prospects of proteolytic enzymes and wound healing. In: Westerhoff W, Vanscheidt W (eds): Proteolytic Enzymes and Wound Healing. New York: Springer-Verlag GmbH & Co., 1994, pp. 99-102.
123. Levenson SM, Gruber DK, Gruber C, Lent R, Seifter E: Chemical debridement of burns: Mercaptans. J Trauma 1981;21:632-644.
124. Burke JF, Golden T: A clinical evaluation of enzymatic debridement with papain urea chlorophylin ointment. Am J Surg 1958;95:828-842.
125. Levenson SM: Debriding agents. J Trauma 1979;19:928-930.
126. Alvarez OM, Fernandez-Obregon AC, Rogers RS, Bergamo L, Masso J, Black M: A prospective randomized comparative study of collagenase and papain-urea for pressure ulcer debridement. Wounds 2002;14:293-301.
127. Alvarez OM, Patel M, Booker J, Markowitz L: Effectiveness of a biocellulose wound dressing for the treatment of chronic venous leg ulcers: Results of a single center randomized study involving 24 patients. Wounds 2004;16(7):224-233.
128. Steed DL, Attinger C, Colaizzi T, Crossland M, Franz M, Harkless L, Johnson A, Moosa H, Robson M, Serena T, Sheehan P, Veves A, Wiersma-Bryant L: Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 2006;14:680-692.
129. Mertz, PM, Alvarez, OM, Smerbeck, RV, Eaglstein WH: A new in vivo model for the evaluation of topical antiseptics on superficial wounds: The effect of 70% alcohol and povidoneiodine solution. Arch Dermatol 1984;120:58-62.
130. Alvarez OM: Pharmacological and environmental modulation of wound healing In: Uitto J, Parejda AJ (eds): Connective Tissue Disease. Molecular Pathology of the Extracellular Matrix. New York: Marcel Dekker, 1987, pp. 367-384.
131. Lineaweaver W, Howard R, Soucy D, McMorris S, Freeman J, Crain C, Robertson J, Rumley T: , Topical antimicrobial toxicity. Arch Surg 1985;120:267-270.
132. Van Den Broek PJ, Buys LMF, Van Furth R: Interaction of povidone-iodine compounds, phagocytic cells, and microorganisms. Antimicrob Agents Chemother 1982;22:593-597.
133. Gruber RP, Vistnes L, Pardoe R: The effect of commonly used antiseptics on wound healing. Plast Reconstr Surg 1975;55:472-476.
134. Gilje, O: On taping (adhesive tape treatment) of leg ulcers, Acta Dermatol Venereol 1948;28:454-467.
135. Winter GD: Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature (London), 1962;193:293-294.
136. Hinman CD, Maibach H: Effect of air exposure and occlusion on experimental human skin wounds, Nature (London) 1963;200:377-379.
137. Alvarez OM, Rozint J, Wiseman D: Moist environment for healing: Matching the dressing to the wound. Wounds 1989;1:35-50.
138. Eaglstein WH, Mertz, PM, Falanga V: Occlusive dressings. Am Fam Physician 1987;35:211-216.
139. Hutchinson JJ, McGuckin M: Influence of occlusive dressings: A microbiological and clinical review, Am J Infect Control 1990;18:257-268.
140. Mott G (ed): Wound Source: The Kestrel Wound Product Sourcebook, 8th ed. Kestrel health Information Inc. Toronto Canada: 2005 〈www.woundsource.com〉 (Last accessed September 2006).
141. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Pendergast JJ, Ricotta JJ, Steed DP, Lipkin S: Use of dermagraft a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19;350-354.
142. Alvarez OM, Mertz PM, Eaglstein WH: The effect of occlusive dressings on collagen synthesis and re-epithelialization in superficial wounds. J Surg Res 1983;35:142-148.
143. Tomic-Canic M, Agren MS, Alvarez OM: Epidermal repair and the chronic wound. In: Rovee DT, Maibach H (eds): The Epidermis in Wound Healing. Boca Raton, FL: CRC Press, 2004, pp. 25-57
144. Alvarez OM, Hefton JM, Eaglstein WE: Healing wound: Occlusion or exposure. Infect Surg 1984;3:173-181.
145. Varghese MC, Balin AK, Carter M, Caldwell D: Local environment of chronic wounds under synthetic dressings. Arch Dermatol 1986;122:52-57.
146. Thomas S: Alginate dressings in surgery and wound management-Part 3. J Wound Care 2000;9:163-166.
147. Ovington LG: The well dressed wound: An overview of dressing types. Wounds 1998;10(Suppl A):1A-11A.
148. Klasen HJ: A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000;26:131-138.
149. Holloway GA, Johansen KH, Barnes RW, Pierce GE: Multicenter trial of cadexomer iodine to treat venous stasis ulcers. West J Med 1989;151:35-38.
150. Apelqvist, J, Ragnarson Tennvall G: Cavity foot ulcers in diabetic patients: A comparative study of cadexomer iodine and standard treatment. An economic analysis alongside a clinical trial. Acta Dermatol Venereol 1996;76:231-235
151. Alvarez OM, Waltrous L, Wendelken M, Markowitz L, Pappous E: Improved healing and down-regulation of gelatinase in neuropathic foot ulcers treated with a primary dressing containing Ca, K, Rb, Zn and total contact cast. Wounds 2007;19:A37.
152. Leipziger LS, Glushko V, DiBernardo B, Shafaie F, Noble J, Alvarez OM: Dermal wound repair: Role of collagen matrix implants and synthetic polymer dressings. J Am Acad Dermatol 1985;12:409-419.
153. Veves A, Sheehan P, Pham HT: A randomized controlled trial of promogran (a collagen/oxidized regenerated cellulose dressing) vs. standard treatment in the management of diabetic foot ulcers. Arch Surg 2002;137:822-827.
154. Szor JK, Bourguignon C: Description of pressure ulcer pain at rest and at dressing change. J Wound Ostomy Continenece Nurs 1999;26:115-120.
155. Roth RS, Lowery JC, Hamill JB: Assesing persistent pain and its relation to affective distress, depressive symptoms, and pain catastrophizing in patients with chronic wounds: A pilot study. Am J Phys Med Rehabil 2004;83:827-834.
156. Moffatt C, Briggs M, Hollinworth H, Meaume S, Pediani R, et al: Understanding wound pain and trauma; An international perspective. In: Caine S, Moffatt C (eds): Pain at Wound Dressing Changes. London: Medical Education Partnership LTD, 2005, pp. 1-17.
157. Cardenas DD, Jensen MP: Treatments for chronic pain in persons with spinal cord injury: A survey study. J Spinal Cord Med 2006;29:109-117.
158. Tan G, Alvarez JA, Jensen MP: Complimentary and alternative medicine approaches to pain management. J Clin Psychol 2006;62:1419-1431.
159. Wardell DW, Rintala DH, Duan Z, Tan G: A pilot study of healing touch and progressive relaxation for chronic neuropathic pain in persons with spinal cord injury. J Holist Nurs 2006;24:231-240.
160. Leighton-Bellichach A: A personal and ethical perspective on chronic wound pain. Br J Nurs 2006;15:909-911.
161. Vingoe FJ: Anxiety and pain: Terrible twins or supportive siblings? In: Gibson HD (ed): Psychology, Pain and Anesthesia. New York: Chapman and Hall, 1994, pp. 282-307.
162. Smith NK, Pasero CL, McCaffery M: Non-drug measures for painful procedures Am J Nurs 1997;97:18-20.
163. Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: An overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001;26:21-29.
164. Lynch ME, Clark AJ, Sawynok J: A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. 2003;19:323-328.
165. Blanke W, Hallern BV: Sharp wound debridement with local anesthesia using EMLA cream: 6 years experience in 1084 patients. Eur J Emerg Med 2003;10:229-231.
166. Friedman PM, Mafong EA, Friedman ES, Geronimus RG: Topical anesthetics update: Emla and beyond. Dermatol Surg 2001;27:1019-1026.
167. Zappetella G, Paul J, Ribeiro MD: Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 2003;25:555-558.
168. Vernassiere C, Cornet C, Trechot P, Alla F, Truchetet F, Cuny JF, Commun N, Granel Brocard F, Barbaud A, Schmutz JL: Study to determine the efficacy of topical morphine on painful chronic skin ulcers. J Wound Care 2005;14:289-293.
169. Twillman RK, Long TD, Cathers TA, Mueller DW: Treatment of painful skin ulcers with topical opioids. J Pain Symptom Man 1999;17:288-292
170. Ribeiro MD, Joel SP, Zeppetella G: The bioavailability of morphine applied topically to cutaneous ulcers. J Pain Symptom Manage 2004;27:434-439.
171. Flock P: Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain Symptom Manage 2003;25:547-554.
172. Sibbald RG, Coutts P, Fierheller M, Woo K: A pilot (real life) randomized clinical evaluation of a pain relieving foam dressing: (ibuprofen-foam versus local best practice). Int Wound J 2007;4:16-23.
173. Price E: Wound care: The stigma of smell. Nurs Times 1996;92:71-72.
174. Sparrow G, Minton M, Rubens RD, Simmons NA, Aubrey C: Metronidazole in smelly tumors. Lancet 1980;1:1185.
175. Finlay IJ, Bowszyc J, Ramlau J, Gwiezdzinski Z: Effect of topical 0.75% metronidazole gel on malodorous cutaneous ulcers. J Pain Symptom Manage 1996;11:158-162.
176. Ashford RF, Plant G, Maher J, Teare L: Double-blind clinical trial of metronidazole in malodorous ulcerating tumors Lancet 1984;1:1232-1233.
177. Levine NS, Lindberg RB, Mason AD, Pruitt BA: The quantitative swab culture and smear: A quick simple method for determining the number of viable bacteria in open wounds. J Trauma 1976;16:89-94.
178. Bornside GH, Bornside BB: Comparison between moist swab and tissue biopsy methods for quantitation of bacteria in experimental incisional wounds. J Trauma 1979;19:103-106.
179. Senneville E, Melliez H, Beltrand E, Legout L, Valette M: Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: Concordance with ulcer swab cultures. Clin Infect Dis 2006;42:57-62.
180. Yapucu Gunes U, Eser I: Effectiveness of a honey dressing for healing pressure ulcers. J Wound Ostomy Continence Nurs 2007;34:184-190.
181. Visavadia BG, Honeysett J, Danford MH: Manuka honey dressing: An effective treatment for chronic wound infections. Br J Oral Maxillofac Surg 2006;Nov 17.
182. Lusby PE, Coombes AL, Wilkinson JM: Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Res 2005;36:464-467.
183. French VM, Cooper RA, Molan PC: The antibacterial activity of honey against coagulase-negative staphylococci. J Antimicrob Chemother 2005;56:228-231.
184. Henriques A, Jackson S, Cooper R, Burton N: free radical production and quenching in honeys with wound healing potential. J Antimicrob Chemother 2006;58:773-777.
185. Tippett A: Novel palliative wound dressings promotes healing. Wounds 2007;19:A25
186. Loitman J, Ward C, Stamn L, Wiersema-Bryant L, Dulle P, et al: Improved pain control at dressing changes with topical lidocaine and morphine as part of a multidisciplinary team for comprehensive wound pain management. Wounds 2007;19:A28.
187. Ford-Dunn S, Belella K, Kirby JP: Use of vacuum assisted closure therapy in the palliation of a malignant wound. Palliat Med 2006;20:477-478.